MedTrace Logo

Real-Time Myocardial Perfusion Echocardiography in the ICU

NCT03173716 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-09-09

No results posted yet for this study

Summary

This study is being done to find out if and how much the use of RTMPE improves a provider's confidence in the diagnosis they assign. This is important because the use of RTMPE may decrease the need for any additional invasive testing.

Conditions

  • Myocardial Perfusion Imaging

Interventions

PROCEDURE

Definity

Real-Time Myocardial Perfusion Echocardiography (RTMPE) will be performed as opposed to the standard echocardiogram (TTE) of the control arm

Sponsors & Collaborators

  • Lantheus Medical Imaging

    collaborator INDUSTRY

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Patricia A. Pellikka · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-28
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03173716 on ClinicalTrials.gov